Proxy Votes Now

Home › Activist investors › Scopia Capital

Scopia Capital

Campaign activist. Positions and campaigns from Scopia Capital’s SEC filings. Updated November 20, 2026.

Filer entities
SCOPIA CAPITAL MANAGEMENT LP
SEC CIK
1279150 (SCOPIA CAPITAL MANAGEMENT LP)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Jun 30, 2026, filed Aug 14, 2026: 19 US-listed positions reported; 0 of 1% or more of a company without a 13D are listed below.
0current positions
0new or changed in 90 days
0active campaigns
3campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (0)

No current position by this definition.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (3)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
Harmonic Inc Stake reported below 5% Jul 12, 2024 Mar 8, 2021 — latest (7) —
Acorda Therapeutics Inc Settled (agreement with the company) Feb 28, 2018 Aug 7, 2017 — latest (2) —
Itron Inc /Wa/ Settled (agreement with the company) Dec 11, 2015 Dec 11, 2015 — latest (1) —
Past positions (1)
CompanyLast stakeSourceOutcomeDate
Harmonic Inc 3.3% Schedule 13D/A, filed Jul 12, 2024 Reported below 5% in a 13D/A Jul 12, 2024

How large managers voted in Scopia Capital’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

3Settlement
Outcome of each campaign (3)
CompanyOutcomeDetailDateFirst filing
Harmonic Inc Settlement agreement with the company Mar 29, 2022 Mar 8, 2021
Acorda Therapeutics Inc Settlement agreement with the company Feb 28, 2018 Aug 7, 2017
Itron Inc /Wa/ Settlement agreement with the company Dec 11, 2015 Dec 11, 2015

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 1 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

Settlement terms

Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.

Acorda Therapeutics Inc · Feb 28, 2018 · Directors named, Ownership cap, Committee role, Standstill

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.